Boston Scientific Corp (BSX)vsKoninklijke Philips NV ADR (PHG)
BSX
Boston Scientific Corp
$56.50
+0.62%
HEALTHCARE · Cap: $83.97B
PHG
Koninklijke Philips NV ADR
$26.16
-0.68%
HEALTHCARE · Cap: $24.89B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 16% more annual revenue ($20.61B vs $17.83B). BSX leads profitability with a 17.3% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.32. BSX earns a higher WallStSmart Score of 71/100 (B).
BSX
Strong Buy71
out of 100
Grade: B
PHG
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-23.3%
Fair Value
$46.11
Current Price
$56.50
$10.39 premium
Margin of Safety
+3.8%
Fair Value
$33.33
Current Price
$26.16
$7.17 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Strong operational efficiency at 20.6%
Generating 1.0B in free cash flow
Growing faster than its price suggests
Reasonable price relative to book value
Generating 1.3B in free cash flow
Areas to Watch
No major concerns identified
1.1% revenue growth
ROE of 7.8% — below average capital efficiency
5.0% margin — thin
Earnings declined 0.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : PHG
The strongest argument for PHG centers on PEG Ratio, Price/Book, Free Cash Flow. PEG of 0.32 suggests the stock is reasonably priced for its growth.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : PHG
The primary concerns for PHG are Revenue Growth, Return on Equity, Profit Margin.
Key Dynamics to Monitor
BSX profiles as a mature stock while PHG is a value play — different risk/reward profiles.
PHG carries more volatility with a beta of 0.92 — expect wider price swings.
BSX is growing revenue faster at 11.6% — sustainability is the question.
PHG generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (71/100 vs 51/100), backed by strong 17.3% margins and 11.6% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Koninklijke Philips NV ADR
HEALTHCARE · MEDICAL DEVICES · USA
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?